首页|常见老年病可干扰p-tau181、Aβ1-42诊断阿尔茨海默病的特异性

常见老年病可干扰p-tau181、Aβ1-42诊断阿尔茨海默病的特异性

扫码查看
目的 探讨老年人多发疾病发病时,如冠心病、脑梗死、慢性肾脏病、肺部感染、高血压、糖尿病等,依据磷酸化tau181和β淀粉样蛋白1-42两指标对诊断阿尔茨海默病时会否产生干扰.方法 回顾性分析2022年5月至2023年4月就诊的阿尔茨海默病30例、老年性疾病(冠心病351例、脑梗死210例、慢性肾脏病237例、肺部感染65例、高血压215例、糖尿病49例)及健康体检30例的磷酸化tau181和β淀粉样蛋白1-42数据,分为阿尔茨海默病组、冠心病组、脑梗死组、慢性肾脏病组、肺部感染组、高血压组、糖尿病组、对照组,统计学分析各组差异,ROC曲线分析两指标联合诊断阿尔茨海默病的价值.结果 磷酸化tau181阿尔茨海默病组(11.8±5.8)低于冠心病组(16.3±12.4)、慢性肾脏病组(16.8±16.3)和肺部感染组(21.4±14.0);β淀粉样蛋白1-42阿尔茨海默病组(29.2±23.4)低于慢性肾脏病组(56.9±64.4)和肺部感染组(53.1±45.1),差异有统计学意义;两指标在阿尔茨海默病组与脑梗死、高血压、糖尿病组均无差异.两指标联合诊断阿尔茨海默病的AUC为 0.713(95%CI 0.641~0.785,P<0.001),Cut-off 分别为 19.8 pg/mL 和 9.5 pg/mL.结论 依据磷酸化 tau181 和 β 淀粉样蛋白1-42对阿尔茨海默病进行筛查时,非阿尔茨海默病老年患者(冠心病、脑梗死、慢性肾脏病、肺部感染、高血压、糖尿病患者)有被误诊为阿尔茨海默病的可能,也会干扰对阿尔茨海默病的辅助诊断及结果解释,需要结合其他检查或评估来排除阿尔茨海默病,避免误诊误治,本研究具有一定临床意义.
Common geriatric diseases can interfere with the specificity of p-tau181 and A β 1-42 in diagnosing Alzheimer's disease
Objective In the presence of senile diseases,such as coronary heart disease,cerebral infarction,chronic kidney disease,pulmonary infection,hypertension,diabetes,to explore the phosphorylated tau 181 and β-amyloidprotein 1-42 in the di agnosis of Alzheimer's disease.Methods 30 cases of Alzheimer's disease,senile diseases(351 cases of coronary heart dis-ease,210 cases of cerebral infarction,237 cases of chronic kidney disease,65 cases of pulmonary infection,215 cases of hyper-tension,49 cases of diabetes)and 30 controls of physical examination of phosphorylated tau 181 and beta amyloid protein 1-42 from May 2022 to April 2023.They were divided into Alzheimer's disease group,coronary heart disease group,cerebral infarction group,chronic kidney disease group,pulmonary infection group,hypertension group,diabetes group,and control grouStatistical analysis of the difference between each group,ROC curve analysis of the value of the two indicators in the diagnosis of Alzheimer's disease.Results It showed that the phosphorylation of tau181 in the Alzheimer's disease group(11.8±5.8)was over than that in the coronary heart disease group(16.3±12.4),chronic kidney disease group(16.8±16.3),and pulmonary infec-tion group(21.4±14.0);β-amyloidprotein 1-42 in Alzheimer's disease group(29.2±23.4)was lower than that in chronic kidney dis ease group(56.9±64.4)and lung infection group(53.1±45.1),with statistically significant differences;There was no difference between the two indexes in Alzheimer's disease group and cerebral infarction,hypertension and diabetes groups.The A UC for the combined diagnosis of Alzheimer's disease with two indicators was 0.713(95%CI:0.641~0.785,P<0.001),with Cut-off values of 19.8 pg/mL and 9.5 pg/mL,respectively.Conclusion When screening Alzheimer's disease according to phosphorylated tau181 and beta amyloid 1-42,elderly patients with non Alzheimer's disease(coronary heart disease,cerebral infarction,chronic kidney disease,pulmonary infection,hypertension,diabetes)may be misdiagnosed as Alzheimer's disease,which will also interfere with the auxiliary diagnosis and interpretation of the results of Alzheimer's disease.It is necessary to exclude Alzheimer's disease in combination with other examinations or assessments to avoid misdiagnosis and mistreatment.This study has certain clinical signifi-cance.

Phosphorylation tau181β-amyloidprotein 1-42Alzheimer's diseaseElderly comorbidities

王学燕、季明德

展开 >

江苏省中医院急诊科南京中医药大学附属医院,江苏南京 210029

江苏省中医院检验科南京中医药大学附属医院,江苏南京 210029

磷酸化tau181 β淀粉样蛋白1-42 阿尔茨海默病 老年性疾病

2024

实验与检验医学
江西省医学会

实验与检验医学

影响因子:1.113
ISSN:1674-1129
年,卷(期):2024.42(4)